Mario Gabelli Abb Vie Inc. Transaction History

Gamco Investors, Inc. Et Al

$9.22 Billion
Q1 2024

A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Abb Vie Inc. stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 14,276 shares of ABBV stock, worth $2.45 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

14,276

Previous 16,255 12.17%

Holding current value

$2.45 Million

Previous $2.42 Million 7.31%

% of portfolio

0.03%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $316,283 - $360,375	-1,979 Reduced 12.17%	14,276 $2.6 Million
Q3 2023 Nov 08, 2023	SELL	$133.59 - $154.65 $2,003 - $2,319	-15 Reduced 0.09%	16,255 $2.42 Million
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $417,008 - $518,940	-3,147 Reduced 16.21%	16,270 $2.19 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $96,165 - $110,749	-665 Reduced 3.31%	19,417 $3.09 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $68,878 - $82,603	498 Added 2.54%	20,082 $3.25 Million

Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $180,109 - $206,574	1,342 Added 7.36%	19,584 $2.63 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $125,371 - $159,388	-911 Reduced 4.76%	18,242 $2.79 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $222,122 - $275,591	-1,683 Reduced 8.08%	19,153 $3.11 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $420,695 - $532,301	-3,916 Reduced 15.82%	20,836 $2.82 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $332,180 - $377,075	3,122 Added 14.43%	24,752 $2.67 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $7,049 - $7,853	67 Added 0.31%	21,630 $2.44 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $83,169 - $91,560	813 Added 3.92%	21,563 $2.33 Million
Q4 2020 Feb 05, 2021	SELL	$80.49 - $108.67 $571,076 - $771,013	-7,095 Reduced 25.48%	20,750 $2.22 Million
Q3 2020 Nov 06, 2020	SELL	$85.91 - $100.83 $1.06 Million - $1.25 Million	-12,384 Reduced 30.78%	27,845 $2.44 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $689,751 - $922,990	9,401 Added 30.5%	40,229 $3.95 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $310,954 - $471,445	4,821 Added 18.54%	30,828 $2.35 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $42,484 - $53,157	589 Added 2.32%	26,007 $2.3 Million
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $972,096 - $1.17 Million	15,435 Added 154.61%	25,418 $1.93 Million
Q2 2019 Aug 02, 2019	BUY	$65.7 - $83.98 $80,088 - $102,371	1,219 Added 13.91%	9,983 $726,000
Q1 2019 May 02, 2019	BUY	$77.14 - $90.79 $66,648 - $78,442	864 Added 10.94%	8,764 $706,000
Q4 2018 Jan 30, 2019	BUY	$77.85 - $96.01 $11,677 - $14,401	150 Added 1.94%	7,900 $728,000
Q3 2018 Nov 02, 2018	SELL	$88.91 - $98.84 $927,775 - $1.03 Million	-10,435 Reduced 57.38%	7,750 $733,000
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $40,580 - $48,015	-452 Reduced 2.43%	18,185 $1.69 Million
Q1 2018 May 09, 2018	SELL	$92.01 - $123.21 $6,440 - $8,624	-70 Reduced 0.37%	18,637 $1.76 Million
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $12,627 - $13,847	-141 Reduced 0.75%	18,707 $1.81 Million
Q3 2017 Nov 01, 2017	BUY	$69.85 - $89.22 $1.32 Million - $1.68 Million	18,848	18,848 $1.68 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track Mario Gabelli's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Account